EN
返回档案库

档案库 · 物流与供应链 · 战略决策 · 2025–2026

Delivrone的AED无人机获法国首个SAMU批准

经过一年的测试,Delivrone的AED无人机获得法国首个SAMU授权,鲁昂急救中心将在2026年向旁观者运送除颤器。

Delivrone

它在赌什么Delivrone押注,与SAMU鲁昂进行为期一年的AED无人机实验能获得监管批准,使其成为常规服务,这在法国尚属首次。已上线

做的是什么生意

Delivrone is a French drone-logistics startup founded in 2021 in Saint-Étienne-du-Rouvray, Normandy, focused on carrying light loads by drone. It developed the emergency-medical drone project with the region's SAMU and works with Sweden's Everdrone, which supplies the aircraft and takeoff infrastructure.

起因

In France about 50,000 people suffer an out-of-hospital cardiac arrest every year, and the CHU de Rouen says the 30-day survival rate is below 5%; a fast shock from a defibrillator multiplies survival chances. Delivrone spent a year trialing an AED drone around Forges-les-Eaux with SAMU 76A, proving it could fit into real emergency calls before asking to use it routinely.

经过

In July 2026, SAMU 76A of the CHU de Rouen obtained the authorization to use the emergency drone — a first in France, which the hospital said required an evolution of drone flight rules under the DSAC civil aviation safety directorate. When a witness calls 15 about a suspected cardiac arrest, the centre can now trigger the drone to carry an AED to within metres of the scene before emergency crews arrive. A base at Bois-Guillaume serves the Rouen métropole, with a second planned further east.

结果

The €300,000 project — Région Normandie contributed €138,000 for the CHU and €113,000 for Delivrone, which invested €40,000 itself — moved from experiment to routine operation, with Delivrone handling operational follow-up alongside Everdrone. The hospital called the rollout a first in France; close to 400 cardiac arrests in people under 75 occur in its intervention zone each year.

背景

Delivrone是诺曼底一家无人机物流初创公司,2021年成立,与鲁昂大学医院的SAMU 76A在福尔日莱欧附近进行了一年的紧急医疗无人机试验。该飞机由瑞典的Everdrone提供,搭载自动体外除颤器,可在调度命令后一分钟内升空。

这次试验在2026年7月取得了回报,SAMU 76A获得授权在日常心脏骤停呼叫中使用无人机——这在法国尚属首次,医院称这需要DSAC民航安全局对无人机飞行规则进行演进。当目击者拨打15电话时,中心现在可以派遣无人机在急救人员到达前将AED投放到现场几米范围内。

这个双基地项目耗资30万欧元,其中诺曼底大区为医院和Delivrone共出资25.1万欧元,Delivrone自己投入4万欧元。Delivrone现在与Everdrone一起运营这项服务,将公共卫生实验转变为法国首个获准的SAMU AED无人机行动。

这件事要成立,得有什么

  • 除颤器只有在使用时才有效:法国大约有50万台除颤器,但旁观者使用率仍然很低,而心脏骤停后快速电击可提高生存几率(BFM Normandie)。
  • 无人机解决了距离问题:约750克的AED可以在调度后约一分钟内到达呼叫者身边,无论昼夜,覆盖200平方公里的区域,而地面急救人员仍在途中(Tendance Ouest)。
  • 福尔格-莱索一年的试验证明了无人机能融入真实的SAMU调度,为医院和监管机构提供了授权常规飞行的证据(BFM Normandie, Tendance Ouest)。
  • 诺曼底大区承担了30万欧元双基地投资中的25.1万欧元,降低了试点风险,直到授权将其转变为服务(Tendance Ouest, Rouen Normandy Invest)。

可借鉴之处

Delivrone一年的真实紧急呼叫试验,而非演示,才是DSAC无人机规则演进和SAMU批准的原因——证据将实验转化为许可服务。

后续进展

从2026年7月起,鲁昂大学医院的SAMU可以在真实心脏骤停呼叫中派遣Delivrone的除颤器无人机,CHU称这是法国首次部署。Delivrone与Everdrone一起从布瓦-纪尧姆基地负责运营跟进,计划在鲁昂大都会以东建立第二个基地;SAMU区域内每年发生近400例75岁以下心脏骤停。该模式能否推广到法国其他急救服务,将取决于DSAC授权的飞行在常规使用中的表现,以及谁为下一个基地提供资金。

资料来源

发现哪里写错了?告诉我们。

轮到你了

你刚读完一家。说说你在做什么,看看谁在赌同一件事。

免费账号 · 3 次免费提问 · 不用绑卡

相关案例